利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

6 条记录 (耗时 0.036 秒)

    Perfumes for linear citrus release in rinse-off systems
    1.
    发明申请
    Perfumes for linear citrus release in rinse-off systems 审中-公开
    在冲洗系统中线性柑橘释放的香水

    公开(公告)号：US20080176781A1

    公开(公告)日：2008-07-24

    申请号：US11657698

    申请日：2007-01-25

    申请人： Addi Fadel ,  Grant Mudge ,  Michael Gordon Evans ,  John Martin Behan

    发明人： Addi Fadel ,  Grant Mudge ,  Michael Gordon Evans ,  John Martin Behan

    IPC分类号： C11D3/50 ,  C11B9/00

    CPC分类号： C11D3/50 ,  C11B9/00

    摘要： Perfume compositions and method of formulating perfume composition are designed for use in wash-off system with a linear citrus perfume release and either any of the following effects: a desired initial release with minimal residual perfume on the targeted system, a long sustained release of fragrance, or a residual deposition of fragrance after use.

    摘要翻译： 香水组合物和配方香料组合物的方法设计用于具有线性柑橘香料释放的洗脱系统和以下任何一种效果：在目标体系上具有最小残留香料的期望的初始释放，长期持续释放的香料 ，或使用后残留的香料沉积物。

    Fragrance compositions
    5.
    发明申请
    Fragrance compositions 审中-公开

    公开(公告)号：US20080096790A1

    公开(公告)日：2008-04-24

    申请号：US11604256

    申请日：2006-11-27

    申请人： John Martin Behan ,  Briony Care ,  Anne Churchill ,  Michael Gordon Evans ,  Keith Douglas Perring ,  Alan Forbes Provan

    发明人： John Martin Behan ,  Briony Care ,  Anne Churchill ,  Michael Gordon Evans ,  Keith Douglas Perring ,  Alan Forbes Provan

    IPC分类号： A61K8/18

    CPC分类号： C11B9/02 ,  C11B9/00 ,  C11B9/0015 ,  C11B9/0019 ,  C11B9/0034 ,  C11B9/0061 ,  C11B9/0069 ,  C11B9/0073 ,  C11B9/008 ,  C11B9/0092

    摘要： A method of promoting activated, pleasant moods through the inhalation of energising, non-stressing fragrances (invigorating fragrances) comprising at least 75% by weight, preferably 85% by weight of perfume materials drawn from the following groups: A) At least 10% by weight in total of at least three materials drawn from Group ‘IMP’ comprising: allyl amyl glycolate; benzyl salicylate; bergamot oil; coriander oil; cyclamen aldehyde; 1-(2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethanone; allyl (cyclohexyloxy)acetate; Damascenia 185 SAE; 2,4-dimethylheptan-1-ol; fir balsam; fir needle oil; 3-(4-ethylphenyl)-2,2-dimethylpropanal; ginger oil; guaiacwood; linalyl acetate; litsea cubeba oil; methyl 2,4-dihydroxy-3,6-dimethylbenzoate; nutmeg oil; olibanum oil; orange flower oil; Ozonal AB 7203C; patchouli oil; rose oxide; rosemary oil; sage clary oil; spearmint oil; Tamarine AB 8212E; tarragon oil; B) Optionally up to 90% of materials from the following groups: Group ‘HMR’ comprising: allyl ionone; benzyl acetate; cis-jasmone; citronellol; ethyl linalol; ethylene brassylate; 4-methyl-2-(2-methylpropyl)tetrahydro-2H-pyran-4-ol; geraniol; geranium oil; isoeugenol; lemon oil; 2,4-dimethylcyclohex-3-ene-1-carbaldehyde; 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; alpha-iso-methyl ionone; 3-methylcyclopentadec-2-en-1-one; cyclopentadecanone; cyclohexadecanolide; gamma-undecalactone. Group ‘HMI’ comprising: 1-{[2-(1,1 -dimethylethyl)cyclohexyl]oxy}butan-2-ol; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1 -{b}]furan; alpha-damascone; dihydromyrcenol; eugenol; 3-(1,3-benzodioxol-5-yl)-2-methylpropanal; 2,4-dimethylcyclohex-3-ene-1-carbaldehyde; mandarin oil; orange oil; 2-(1,1-dimethylethyl)cyclohexyl acetate. Group ‘HMP’ comprising: 1-(2,6,6,8-tetramethyltricyclo[5.3.1.0 {1,5}]undec-8-en-9-yl)ethanone; allyl cyclohexyl propionate; allyl heptanoate; Apple Oliffac S pcmf; 7-methyl-2H-1,5-benzodioxepin-3(4H)-one; cassis base; cis-3-hexenyl salicylate; damascenone; gamma-decalactone; ethyl acetoacetate; ethyl maltol; ethyl methyl phenylglycidate; hexyl acetate; (3E)-4-methyldec-3-en-5-ol; 2,5,5-trimethyl-6,6-bis(methyloxy)hex-2-ene; 4-(4-hydroxyphenyl)butan-2-one; styrallyl acetate; 2,2,5-trimethyl-5-pentylcyclopentanone; ylang oil. Group ‘RMP’ comprising: anisic aldehyde; (2Z)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; benzoin siam resinoid; ethyl vanillin; oxacyclohexadec-12(13)-en-2-one; hexyl salicylate; hydroxycitronellal; jasmin oil; 3-methyl-5-phenylpentan-1-ol; 2-(phenyloxy)ethyl 2-methylpropanoate; alpha-terpineol; vanillin; Group ‘GEN’ comprising: cyclopentadecanolide; oxacyclohexadecan-2-one; hexyl cinnamic aldehyde; ionone beta; isobornyl cyclohexanol; 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7(8),8(8a)-octahydronaphthalen-2-yl)ethanone; 4-(1,1-dimethylethyl)phenyl]-2-methylpropanal; linalol; methyl dihydrojasmonate; 2-phenylethanol; provided the following conditions are met: (a) IMPs>=HMPs+HMRs (b) IMPs+HMIs+GENs>=70% (c) (IMP+HMI)/(IMP+HMI+RMP+HMR)>=0.7 (d) IMPs/(HMPs+RMPs+IMPs)>=0.5 (e) IMPs/[(HMPs+RMPs+IMPs)+(100−TOTAL)]>=0.3 wherein ‘IMPs’ indicates the sum of the percentages of materials within Group IMP, and similarly for the remaining groups, the symbol ‘>=’ indicates ‘at least equal to’, and ‘TOTAL’ is the sum of HMPs, HMRs, HMIs, IMPs, RMPs and GENs, provided also that low odour or no odour solvents are excluded from the calculation of these sums is provided which have an invigorating effect when inhaled by a subject.